From: Nitric Oxide: A Physiologic Messenger

Slides:



Advertisements
Similar presentations
Nitric oxide…Neurotransmitter? B.Sc EDRF: endothelium-derived relaxing factor Furchgott in 1980 showed that Acetylcholine-stimulated relaxation.
Advertisements

03/06/021 K June /06/ Vascular Smooth Muscle Cells Endothelium Neural Other Tissues Intrinsic Factors Regulation of Flow (Q)
CHMI E.R. Gauthier, Ph.D. 1 CHMI 2227E Biochemistry I Enzymes: - Inhibition.
Part V Second Messengers. The first messengers being the extracellular signal molecules and the third messengers being the large protein kinases and phosphatases.
Membrane Function Signal Transduction. I. Introduction to Receptors & Signal Transduction.
Today’s lecture More about G proteins Second messengers from lipids Calcium is a second messenger Nitric oxide is a second messenger more neat things about.
Date of download: 5/27/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Efficacy and Safety of Tadalafil in Men With Erectile.
Date of download: 5/31/2016 From: Polymorphonuclear Leukocytes in Non-Insulin-dependent Diabetes Mellitus: Abnormalities in Metabolism and Function Ann.
Date of download: 6/3/2016 From: Sex, Age, and Birth Cohort Effects in Colorectal Neoplasms: A Cohort Analysis Ann Intern Med. 2010;152(11): doi: /
Date of download: 6/23/2016 From: Meta-Analysis: Acupuncture for Low Back Pain Ann Intern Med. 2005;142(8): doi: /
Date of download: 6/25/2016 Copyright © The American College of Cardiology. All rights reserved. From: Myocardial Microvascular Inflammatory Endothelial.
Date of download: 7/6/2016 From: Can Inexpensive Signs Encourage the Use of Stairs? Results from a Community Intervention Ann Intern Med. 1998;129(5):
Date of download: 7/9/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Role of the Natriuretic Peptide System in Cardiorenal.
Date of download: 9/17/2016 From: Topical Treatment of Pressure Ulcers with Nerve Growth Factor: A Randomized Clinical Trial Ann Intern Med. 2003;139(8):
Date of download: 9/18/2016 From: The Cardiomyopathy of Overload: An Unnatural Growth Response in the Hypertrophied Heart Ann Intern Med. 1994;121(5):
Date of download: 9/19/2016 Copyright © The American College of Cardiology. All rights reserved. From: Coronary endothelial dysfunction in the insulin-resistant.
Polymorphisms in endothelial nitric oxide synthase and atherogenesis
From: Screening for Syphilis Infection in Pregnancy: U. S
Ann Intern Med. 2007;147(10): doi: / Figure Legend:
From: Two Ways of Knowing: Big Data and Evidence-Based Medicine
Ann Intern Med. 2011;155(7): doi: / Figure Legend:
Ann Intern Med. 2010;153(7): doi: / Figure Legend:
Ann Intern Med. 2016;165(7): doi: /M Figure Legend:
From: Effects of Pulmonary Rehabilitation on Physiologic and Psychosocial Outcomes in Patients with Chronic Obstructive Pulmonary Disease Ann Intern Med.
From: High-Dose Melphalan and Autologous Stem-Cell Transplantation in Patients with AL Amyloidosis: An 8-Year Study Ann Intern Med. 2004;140(2):85-93.
From: Effects of Low-Carbohydrate and Low-Fat DietsA Randomized Trial
From: Systematic Review: Comparative Effectiveness of Treatments to Prevent Fractures in Men and Women with Low Bone Density or Osteoporosis Ann Intern.
Ann Intern Med. 2005;143(6): doi: / Figure Legend: Flow of evidence.
From: Idiopathic Pulmonary Fibrosis: Prevailing and Evolving Hypotheses about Its Pathogenesis and Implications for Therapy Ann Intern Med. 2001;134(2):
Ann Intern Med. 2014;160(11): doi: /M Figure Legend:
Ann Intern Med. 1999;130(6): doi: / Figure Legend:
Figure Legend: From: Immune Modulation by Volatile Anesthetics
From: Medicare Chronic Care Management Payments and Financial Returns to Primary Care PracticesA Modeling Study Ann Intern Med. 2015;163(8): doi: /M
From: Systematic Review: Strategies for Using Exercise Therapy To Improve Outcomes in Chronic Low Back Pain Ann Intern Med. 2005;142(9): doi: /
From: The Evolving Diabetes Burden in the United States
From: Long-Term Outcome of Anti–Glomerular Basement Membrane Antibody Disease Treated with Plasma Exchange and Immunosuppression Ann Intern Med. 2001;134(11):
From: The In-Training Examination in Internal Medicine: An Analysis of Resident Performance over Time Ann Intern Med. 2002;137(6): doi: /
Stimulation of α2Adrenoceptors Dilates the Rat Middle Cerebral Artery
From: Meta-Analysis: Pharmacologic Treatment of Obesity
Ann Intern Med. 2014;160(9): doi: /M Figure Legend:
From: Treatment of Refractory Whipple Disease with Interferon-γ
From: Screening for Lung Cancer With Low-Dose Computed Tomography: A Systematic Review to Update the U.S. Preventive Services Task Force Recommendation.
From: Doctoring to the Music of Time
From: A 10-Year Experience with Universal Health Insurance in Taiwan: Measuring Changes in Health and Health Disparity Ann Intern Med. 2008;148(4):
From: Exercise Tomographic Thallium-201 Imaging in Patients with Severe Coronary Artery Disease and Normal Electrocardiograms Ann Intern Med. 1994;121(11):
From: Self-Measured Blood Pressure Monitoring in the Management of HypertensionA Systematic Review and Meta-analysis Ann Intern Med. 2013;159(3):
Design of a Wireless Biological Signal Conditioning System1
Endothelium-derived mediators: the vasodilators prostacyclin (PGI2) and nitric oxide (NO) and the vasoconstrictor endothelin (ET-1). Endothelium-derived.
Signal trasduction via cAMP
HFpEF, a Disease of the Vasculature: A Closer Look at the Other Half
Long-acting oral phosphodiesterase inhibition preconditions against reperfusion injury in an experimental lung transplantation model  Eric S. Weiss, MD,
The key pathways and classes of drugs that have been approved for the treatment of pulmonary arterial hypertension. The key pathways and classes of drugs.
Physiology of the endothelium
Vascular endothelial dysfunction in cirrhosis
Daniel A. Langer, Vijay H. Shah  Journal of Hepatology 
Divya Gupta et al. JCHF 2013;1:
Evaluation of the microcirculation in vascular disease
Pharmacology of coronary artery bypass grafts
The sources of oxidative stress in the vessel wall
Key pathways involved in the pathogenesis of pulmonary arterial hypertension: a) endothelin (ET) pathway; b) nitric oxide pathway; and c) prostacyclin.
Guo-Wei He, MD, DSc, David P. Taggart, FRCS 
Thomas Quaschning, Jan Galle, Christoph Wanner
Margus Annuk, Mihkel Zilmer, Bengt Fellström
Mary P. Kotlarczyk, PhD, Marie Billaud, PhD, Benjamin R
Volume 75, Issue 3, Pages (February 2009)
Evaluation and Medical Management of Erectile Dysfunction
Role of Nitric Oxide Pathway in Placental Dysfunction Following Fetal Bypass  Christopher Lam, BS, R. Scott Baker, BS, Jerri McNamara, CCP, Robert Ferguson,
Hypoxic pulmonary vasoconstriction in cardiothoracic surgery: basic mechanisms to potential therapies  Ben M Tsai, MD, Meijing Wang, MD, Mark W Turrentine,
Mechanism of action for pulmonary arterial hypertension medications.
Evaluation and Medical Management of Erectile Dysfunction
Presentation transcript:

From: Nitric Oxide: A Physiologic Messenger Ann Intern Med. 1994;120(3):227-237. doi:10.7326/0003-4819-120-3-199402010-00009 Figure Legend: Nitric oxide arterial smooth muscle.A messenger molecule such as acetylcholine binds to the acetylcholine receptor on an endothelial cell, activating inward calcium currents. Calcium binds to calmodulin and activates endothelial cell nitric oxide synthase, which converts arginine plus oxygen into citrulline and nitric oxide. Nitric oxide diffuses out of the endothelial cell into an adjacent smooth muscle cell and activates guanylate cyclase by binding to the iron in its heme group. The increase in cyclic guanosine monophosphate (cGMP) causes smooth muscle relaxation, and thus vasodilation. GTP = guanosine triphosphate. Date of download: 11/12/2017 Copyright © American College of Physicians. All rights reserved.